Navigation Links
National Organization for Rare Disorders To Partner With Discovery Health and 'MYSTERY DIAGNOSIS' for Rare Disease Day 2009
Date:2/9/2009

- NORD Names Discovery Health Media Partner and MYSTERY DIAGNOSIS Program Partner for First Rare Disease Day in U.S. on February 28, 2009 -

- MYSTERY DIAGNOSIS Airs Mondays at 10PM ET/PT on Discovery Health -

DANBURY, Conn., Feb. 9 /PRNewswire/ -- The National Organization for Rare Disorders (NORD) announced that Discovery Health and its popular series, MYSTERY DIAGNOSIS, will serve as media and program partners for Rare Disease Day on February 28, 2009. This year represents the first U.S. observance of Rare Disease Day, an event designed to call attention to the public health issues associated with rare diseases affecting nearly 30 million Americans and countless others worldwide. NORD and its 145 partner organizations serve as advocates for these patients by helping heighten awareness of their conditions and the need for increased research funding for effective treatments. Information on Rare Disease Day will also be featured on Discovery Health and online on DiscoveryHealth.com.

Discovery Health's award-winning MYSTERY DIAGNOSIS chronicles the experiences of patients who suffer from conditions outside of the medical mainstream. Often the diseases profiled on MYSTERY DIAGNOSIS are the rare or "orphan" conditions represented by NORD. Each episode features patients who are initially misdiagnosed or undiagnosed altogether due to the uncommon nature of their symptoms and general lack of awareness regarding their conditions.

Ashley Kurpiel of Atlanta has been selected to serve as a patient spokesperson for Rare Disease Day. Featured on the episode of MYSTERY DIAGNOSIS premiering March 2 at 10PM ET/PT, Ashley had her arm erroneously amputated due to a doctor's misdiagnosis of her rare disease during her childhood. At the age of 3, Ashley was finally diagnosed with Fibrodysplasia Ossificans Progressiva (FOP,) one of the most disabling conditions
'/>"/>

SOURCE Discovery Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., The National Comprehensive Cancer Network (NC...ent that details a draft paradigm for near-term co... upon existing data. The document introduces the N...sensus-based process that compares the risk-versus...d in the NCCN Clinical Practice Guidelines in Onco...
(Date:11/9/2009)..., March of Dimes Names 2010 National Ambassad...USNewswire/ -- Joshua Hoffman of Weston, Fla., was...ans that doctors could not say whether he would su...ar. Today, the 6-year-old was named March of Dimes...lanie Hoffman, recalls, "My first minutes of mothe...
(Date:11/9/2009)..., NEW YORK, Nov. 9 Th...l make its world television debut on the Sundance ...8 p.m. EST/PST. ,, Directed by Academy Award&#...journeys of children with type 1 diabetes amid the...one the world,s poorest countries. The children ar...
(Date:11/9/2009)..., NEW YORK, Nov. 9 /PRNewswire/ -- Phoenix ...nd drug abuse treatment and prevention program, an...., a nationally and internationally recognized lea...Chief Clinical Officer, effective January 1, 2010.... of substance abuse treatment research and her wor...
(Date:11/9/2009)..., CAMBRIDGE, Mass., Nov. 9 Ab...d capabilities in delivering emergency management ...y awarded contracts to support the work of the Fed...f Regional Operations, the National Commission on ...itan Area Transit Authority (WMATA). The value of...
Breaking Medicine News(10 mins):Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2
...dy finds that youth populations with sickle cell d...and thus may fail to benefit from scientific advan...ncer , finds that the patients, mostly African Ame...ed blood cells, affects close to 100,000 persons i...
...sful results from use of its patented personalized..., Inc. is working on advancing the P3T family of p...T. MEDRAD will demonstrate some of these potential...ized patient injection protocols are showing promi...
...o carry same dangers, study finds , , MOND...abetes drug Avandia -- already controversial becau...r than Actos, another drug in the same class, rese...itazone), both of which are part of a class of dru...
...just talk about eating healthfully, they make heal...ssociation,s (ADA,s) Food and Culinary Professiona...st, Fresh & Flavorful" recipe contest sponsore...s were that they must include at least 2 tablespoo...
...00 square feet to top pediatric research instituti...s) November 24, 2008 -- Children,s National Medica...itute , dedicated new research facilities today, i...ic leaders from the community joined the faculty o...
...the pioneer,in applying advanced technology to emu...out the coach -- for wellness, disease management,...g well, has introduced one of its most,comprehensi...arriers that prevent them from being physically ac...
Other Medicine News:Health News:Children with sickle cell disease receiving inadequate care 2Health News:MEDRAD Builds on Success of P3T Cardiac CT Injection Software 2Health News:MEDRAD Builds on Success of P3T Cardiac CT Injection Software 3Health News:MEDRAD Builds on Success of P3T Cardiac CT Injection Software 4Health News:Avandia's Heart Risk Higher Than Others in Its Class 2Health News:Avandia's Heart Risk Higher Than Others in Its Class 3Health News:Avandia's Heart Risk Higher Than Others in Its Class 4Health News:Three Chef-Dietitians Win CanolaInfo Recipe Contest 2Health News:Children's National Dedicates New Research Facility 2Health News:Children's National Dedicates New Research Facility 3Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 2Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 3Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 4Health News:HealthMedia Announces Industry's First Individually Tailored Physical Activity Intervention and Other Innovative New Program Features 5
(Date:11/9/2009)... TOWN OF HEMPSTEAD, N.Y., Nov. 9 /PRNewswire/ -- ...ice officers and other rescue workers came togethe...ty. Merrick firefighter Brian McCauley was one of ... save his own life. ,, Only in his late 30s, Mc...ndergone surgery and extensive chemotherapy treatm...
(Date:11/9/2009)... PALO ALTO, Calif., Nov. 9 Women,s...t has changed its name to Viveve as it prepares fo... select U.S. markets. ,, "Viveve is a name that...cus on women,s sexual health," said Kerry Pope, Vi...ts for the sole purpose of helping women restore t...
(Date:11/9/2009)... NATICK, Mass., Nov. 9 B...nnounced the launch of its COGNIS® cardiac re...TELIGEN® implantable cardioverter defibrillat... the Japanese Ministry of Health, Labor and Welfar...oval in September. COGNIS and TELIGEN are the res...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 1Microbes and their hosts exploring the complexity of symbiosis in DNA and cell biology 9396 2Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 1Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...05, 2007 /PRNewswire/ -- Results from,the primary ...Phase,3 study showed that 77 percent of treatment-...TM) (darunavir) 600 mg tablets with,100 mg ritonav...kground regimen (OBR) of antiretroviral (ARV) agen...at week 48, compared to 68,percent of patients tak...
...INESS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncology, Inc....ta,from an ongoing phase II trial of ZIO-201 (isop...oma patients was presented at the,European Society...,2007 in Lugano, Switzerland. The abstract entitle...Sarcoma," was presented by,Rashmi Chugh, MD, a Pri...
Other Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
...efabricated foot and ankle products resolves a wid...ability to foot malalignment. Ossur products uniqu... and energy-return technology., ,Age is not impor...ot orthoses provide a measure of support, but peop...
...rigid shell with a vacuum liner used to provide su...t is a non-weight bearing splint. Once the patient...to the STORM walker boot., ,Patients requiring ma... the STORM and insert the vacuum liner from the Va...
Active Ankle Orthosis(Trainers)
Bledsoe Wee Walker Boot
Medicine Products: